Worldwide Veterinary Dermatology Drugs Industry to 2031 - Featuring Bayer, Bimeda and Ceva Sante Animale Among Others

News provided by

Aug 31, 2021, 08:15 ET

DUBLIN, Aug. 31, 2021 /PRNewswire/ -- The "Veterinary Dermatology Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031" report has been added to ResearchAndMarkets.com's offering.

This report on the global veterinary dermatology drugs market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031. The report provides the overall revenue of the global veterinary dermatology drugs market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global veterinary dermatology drugs market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players' literature, annual reports, press releases, and relevant documents to understand the global veterinary dermatology drugs market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global veterinary dermatology drugs market.

The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Additionally, the report sheds light on the changing competitive dynamics in the global veterinary dermatology drugs market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global veterinary dermatology drugs market. The next section of the global veterinary dermatology drugs market report highlights the USPs, which include technological advancements, key industry events (mergers, acquisitions, strategic partnerships, etc.), top 3 players operating in the market, and COVID-19 pandemic impact on the global veterinary dermatology drugs market.

The report delves into the competitive landscape of the global veterinary dermatology drugs market. Key players operating in the global veterinary dermatology drugs market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global veterinary dermatology drugs market report.

Key Questions Answered in the Report

What are the sales/revenue generated by end users of veterinary dermatology drugs across all regions during the forecast period?
What are the key trends in the global veterinary dermatology drugs market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which segment will have the highest revenue globally in 2031 and which segment will expand at the highest CAGR during the forecast period?

Key Topics Covered:

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Veterinary Dermatology Drugs Market

4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Veterinary Dermatology Drugs Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Regulatory Scenario by Region/globally
5.3. Cost of Veterinary Dermatological treatments
5.4. List of Veterinary Dermatological Products Manufacturing Facilities, by Key Region
5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
6.3.1. Antifungal Drugs
6.3.2. Antibacterial Drugs
6.3.3. Antiparasitic Drugs
6.3.4. Others
6.4. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Product Type

7. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Mode of Administration
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Mode of Administration, 2017-2031
7.3.1. Topical
7.3.2. Oral
7.3.3. Injectable
7.4. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Mode of Administration

8. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Animal Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Animal Type, 2017-2031
8.3.1. Large Animals
8.3.1.1. Equine
8.3.1.2. Bovine
8.3.1.3. Others
8.3.2. Small Animals
8.3.2.1. Cat
8.3.2.2. Dogs
8.3.2.3. Others
8.4. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Animal Type

9. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Indication
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Indication, 2017-2031
9.3.1. Infectious Diseases
9.3.2. Skin Cancer
9.3.3. Autoimmune Skin Diseases
9.3.4. Parasitic Infections
9.3.5. Others
9.4. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Indication

10. Global Veterinary Dermatology Drugs Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Veterinary Dermatology Drugs Market Value (US$ Mn) Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Veterinary Dermatology Drugs Market Attractiveness Analysis, by Region

11. North America Veterinary Dermatology Drugs Market Analysis and Forecast

12. Europe Veterinary Dermatology Drugs Market Analysis and Forecast

13. Asia Pacific Veterinary Dermatology Drugs Market Analysis and Forecast

14. Latin America Veterinary Dermatology Drugs Market Analysis and Forecast

15. Middle East & Africa Veterinary Dermatology Drugs Market Analysis and Forecast

16. Competitive Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Company Profiles
16.2.1. Bayer
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. Strategic Overview
16.2.1.5. SWOT Analysis
16.2.2. Bimeda, Inc.
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Financial Overview
16.2.2.3. Product Portfolio
16.2.2.4. Strategic Overview
16.2.2.5. SWOT Analysis
16.2.3. Boehringer Ingelheim GmbH
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. Strategic Overview
16.2.3.5. SWOT Analysis
16.2.4. Ceva Sante Animale
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. Strategic Overview
16.2.4.5. SWOT Analysis
16.2.5. Eli Lilly and Company
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Financial Overview
16.2.5.3. Product Portfolio
16.2.5.4. Strategic Overview
16.2.5.5. SWOT Analysis
16.2.6. Merck Animal Health
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. Strategic Overview
16.2.6.5. SWOT Analysis
16.2.7. Sanofi S.A.
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Financial Overview
16.2.7.3. Product Portfolio
16.2.7.4. Strategic Overview
16.2.7.5. SWOT Analysis
16.2.8. Virbac
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Financial Overview
16.2.8.3. Product Portfolio
16.2.8.4. Strategic Overview
16.2.8.5. SWOT Analysis
16.2.9. Zoetis, Inc.
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Financial Overview
16.2.9.3. Product Portfolio
16.2.9.4. Strategic Overview
16.2.9.5. SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/8zchex

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets